Thursday, 24 September 2020

EISAI RECEIVES POSITIVE OPINION FROM EMA’S CHMP ON USE OF ANTIEPILEPTIC AGENT FYCOMPA® IN PEDIATRIC PATIENTS



source https://www.pharmatutor.org/pharma-news/2020/eisai-receives-positive-opinion-from-emas-chmp-on-use-of-antiepileptic-agent
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...